Company Information
Sherlock Biosciences was founded on January 2019. The company is based in Cambridge, MA, USA . The number of employees in Sherlock Biosciences is less than 50. Sherlock biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.Funding & investors
Sherlock Biosciences has received 3 rounds of venture funding. The total funding amount is around $56M.- Open Philanthropy Project (Venture capital)
- Northpond Ventures (Venture capital)
- Baidu Ventures (Venture capital)
Similar Companies [beta]
Venture Categories
Active Venture Investors
- Active Investors in Biotechnology
- Active Investors in Health Care
- Active Investors in Science And Engineering
Venture Competitors
- Best Funded Biotechnology Startups
- Best Funded Health Care Startups
- Best Funded Science And Engineering Startups
News
Sherlock Biosciences - Blog
- SynBioBeta BioPharma Virtual Conference featuring Rahul Dhanda
- The 10 most innovative biotechnology companies of 2021
- Sherlock Biosciences Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021
- How Sherlock’s COVID-19 Test Detects Variants
- Sherlock Biosciences says COVID-19 could change diagnostics forever
- Virtual Event: IFCC Global Conference on COVID-19 – Presentation by Will Blake, CTO: CRISPR and Synthetic Biology-based Solutions Applied to COVID-19 Diagnosis
Company among top-ranked in the biotechnology category Cambridge, Mass., March 9, 2021 – Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021. The list honors the businesses that … Read more
Share:
